Trials / Completed
CompletedNCT02073019
A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers
A Phase I, Two Part Study Exploring the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effect of Ascending Doses of BL-8040 in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- BioLineRx, Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether BL-8040 is safe, tolerable and effective in the mobilization of Hematopoietic Stem Cells (HSC) in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BL-8040 | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-02-27
- Last updated
- 2015-07-31
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02073019. Inclusion in this directory is not an endorsement.